DOCTAR
InactiveSignals
Two signals. The signal on the left, the evidence on the right.
○neutral
neutral · No filing for years
The last filed financial year closed on 31-12-2020. Since then, 5 financial years are missing. This points to a standstill, not an imminent failure.
NBB · 8 filingsPosition against the passed deadline
31-12-2021 close31-07-2022 deadline01-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2020 was due by 31-07-2021 and was filed on 06-08-2021, 6 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
not filed
2020
6 d late
2019
34 d late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 2 accounts on average 20 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
Financials · fiscal year 2020, abbreviated schema
Equity
€120,757
2019 · -€507,840
Total assets
€774,919▲ 209%
2019 · €250,433
Net result
€631,848
2019 · -€41,988
Working capital
€120,657
2019 · -€565,375
Trend over the years
In euros
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line201820192020
Operating result-€75,462--€76,552▼ 1.4%€653,041
Net result-€177,864--€41,988▲ 76.4%€631,848
Equity-€462,852--€507,840▼ 9.7%€120,757
Total assets€497,426-€250,433▼ 49.7%€774,919▲ 209%
Debt€960,278-€758,273▼ 21.0%€654,162▼ 13.7%
Working capital-€578,064--€565,375▲ 2.2%€120,657
Staff (FTE)0.8-0.8=
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2020: €653,041 after a loss of €76,552 in 2019, the highest result in the available series.
Balance-sheet composition
2020 in colour, 2019 as the grey bar beneath
Assets €774,919
Fixed assets
€100 ▼ 99.9%
Current assets
€774,819 ▲ 388%
Equity and liabilities €774,919
Equity
€120,757
Debt
€654,162
Debt finances 84.4% of the balance-sheet total.
Key figures and ratios
EBITDA
€712,210▲
2019 · -€18,932
Cash flow
€691,017▲
2019 · €15,632
Current ratio
1.18▲
2019 · 0.22
ROE
523.2%
ROA
81.5%▲
2019 · -16.8%
Debt ≤ 1 year
€654,162▼
2019 · €724,080
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2018 | 2019 | 2020 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29,820 | €57,620 | €59,169 | ▲ 2.7% |
| Gross operating margin9900 | -€8,182 | €22,695 | €717,400 | ▲ 3,061% |
| Operating profit (loss)9901 | -€75,462 | -€76,552 | €653,041 | ▲ 953% |
| Recurring financial income75 | - | - | €106 | - |
| Recurring financial charges65 | €2,691 | €436 | €426 | ▼ 2.2% |
| Profit (loss) for the period before taxes9903 | -€177,864 | -€41,988 | €631,848 | ▲ 1,605% |
| Profit (loss) for the period9904 | -€177,864 | -€41,988 | €631,848 | ▲ 1,605% |
| Profit (loss) for the period to be appropriated9905 | -€177,864 | -€41,988 | €631,848 | ▲ 1,605% |
| Line | 2018 | 2019 | 2020 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €497,426 | €250,433 | €774,919 | ▲ 209% |
| Fixed assets21/28 | €118,862 | €91,727 | €100 | ▼ 99.9% |
| Intangible fixed assets21 | €118,484 | €91,627 | - | - |
| Tangible fixed assets22/27 | €278 | - | - | - |
| Financial fixed assets28 | €100 | €100 | €100 | = |
| Current assets29/58 | €378,564 | €158,705 | €774,819 | ▲ 388% |
| Amounts receivable within one year40/41 | €1,250 | €1,606 | €87,264 | ▲ 5,335% |
| Cash at bank and in hand54/58 | €377,314 | €157,100 | €687,555 | ▲ 338% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €497,426 | €250,433 | €774,919 | ▲ 209% |
| Equity10/15 | -€462,852 | -€507,840 | €120,757 | ▲ 124% |
| Contributions10/11 | €522,750 | €519,750 | - | - |
| Profit (loss) carried forward14 | -€985,602 | -€1.0m | -€395,743 | ▲ 61.5% |
| Amounts payable17/49 | €960,278 | €758,273 | €654,162 | ▼ 13.7% |
| Amounts payable within one year42/48 | €956,628 | €724,080 | €654,162 | ▼ 9.7% |
| Trade debts44 | €14,803 | €16,244 | €20,789 | ▲ 28.0% |
| Line | 2018 | 2019 | 2020 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€177,864 | -€41,988 | €631,848 | ▲ 1,605% |
| + Depreciation and write-downs630 | €29,820 | €57,620 | €59,169 | ▲ 2.7% |
| Operating cash flow (approximation) | -€148,044 | €15,632 | €691,017 | ▲ 4,321% |
| Investment in fixed assets (approximation) | - | -€30,485 | €32,458 | ▲ 206% |
| Change in cash | - | -€220,214 | €530,456 | ▲ 341% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2021
06-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 6 days late
2020
31-12
Financial
Back to profitnet €631,848
Net result €631,848 after 2 loss-making years.
31-12
Financial
Liquidity times 5current ratio 1.18
Current ratio from 0.22 to 1.18; short-term debt falls from €724,080 to €654,162.
31-12
Financial
Equity above €100,000Eq €120,757
Equity rises from -€507,840 to €120,757.
03-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 34 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
21-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
16-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 16 days late
2015
31-08
NBB filing
Annual accounts filed
fiscal year 2014 · abbreviated schema · 31 days late
2014
24-06
NBB filing
Annual accounts filed
fiscal year 2013 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Owners and holdings
2 ownersChain of control
- MEDIPSY
- DOCTAR
Highest known parent: MEDIPSY. The sources do not say who stands above it.
Owners 2
- MEDIPSYparentSourceaccounts MEDIPSY 2024100%
-
0.07%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.